权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Modulation of tumor inflammatory factor for immune therapy

调节肿瘤炎症因子用于免疫治疗

基本信息

批准号：
9754789
负责人：
Shu-Hsia Chen
金额：
$ 44.96万
依托单位：
METHODIST HOSPITAL RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-09-22 至 2022-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9754789
关键词：
Affect Antibodies Biological Process Blocking Antibodies Cancer Patient Cell Differentiation process Cell physiology Chronic Development Disease Exhibits Genes Human Immune Immune Evasion Immunologic Factors Immunosuppression Immunosuppressive Agents Immunotherapy Infiltration Inflammation Inflammatory Inflammatory Response Interleukin-1 beta Interleukin-6 Knockout Mice Malignant - descriptor Malignant Neoplasms Mediating Membrane Membrane Fluidity Membrane Microdomains Modality Modeling Molecular Mechanisms of Action Mus Myelogenous Myeloid Cells Myeloid-derived suppressor cells Neoplasm Metastasis Neoplasm Transplantation Phenotype Play Proteins Regulation Role Signal Pathway Signal Transduction Small Interfering RNA T-Lymphocyte TNF gene Testing Translating Transmembrane Domain Tumor Angiogenesis Tumor Immunity Tumor Tissue Tumor-associated macrophages angiogenesis base cancer immunotherapy checkpoint therapy chemokine clinical translation cytokine hypoxia inducible factor 1 knock-down macrophage member microbiome monocyte neoplastic cell novel novel therapeutics pathogen recruit response success transcription factor tumor tumor growth tumor microenvironment tumor progression tumorigenesis

项目摘要

The study of tumor-associated inflammatory factors is essential for determining the relationship between the tumor microenvironment and tumorigenesis. Myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAM) within the tumor microenvironment have been shown to promote tumor progression and metastasis. Despite the initial promise of T cell checkpoint inhibitor therapies in treating cancer patients, the immunosuppressive tumor-promoting microenvironment established by TAMs and MDSCs remains a major barrier to complete success. Using qPCR superarrays, we identified an important tumor factor, CKLF-like MARVEL transmembrane domain containing 4 (CMTM4), a member of the chemokine-like factor superfamily, which is highly expressed in human and mouse tumor cells and tissues. Preliminary studies showed that CMTM4 plays a significant role in the regulation of tumor-associated inflammation and establishment of a suppressive tumor microenvironment. siRNA knockdown (KD) of CMTM4 in tumor led to a significant reduction in tumor growth and angiogenesis in multiple tumor types. Myeloid specific CMTM4 deficiency results in significantly retarded tumor development in transplanted tumor models. Most interestingly, myeloid cells from CMTM4 KO mice skew toward M1 classical functional activation and maturation, which, in turn, plays an important role in the regulation of inflammatory cytokines and inflammation-related transcription factors (e.g. IL-6, TNFalpha, IL- 1beta, NFkappaB, HIF1alpha, IRF5, and IRF8). We hypothesize that CMTM4 is a key factor in controlling inflammatory signals and subsequently affects the tumor microenvironment through recruitment and differentiation of MDSCs toward an “M2-like”, alternatively activated, phenotype that promotes angiogenesis and immune evasion, thereby facilitating tumor progression. Therefore, modulation of CMTM4-regulated inflammatory responses may convert an immune-suppressive tumor microenvironment into an immune- conducive one. In this proposal, three specific aims will be pursued to test our hypothesis: 1) CMTM4 is the key driver that controls tumor inflammation. 2) Modulate the function of myeloid cells through CMTM4. Studies of the cellular and molecular mechanisms of action utilized by CMTM4 are critical for clinical translation. CMTM4 KD can alter the tumor microenvironment, enhance anti-tumor immunity, and control tumor cell progression. Successful completion of these studies will lead to a better understanding of how our findings with mouse CMTM4 can be translated to human studies. The scientific information gained will have a significant impact on targeting TAMs/MDSC to revert the immune suppression associated with advanced malignancies and facilitate development of a novel therapeutic modality for the regulation of chronic inflammatory diseases.

肿瘤相关炎症因子的研究对于确定肿瘤与肿瘤之间的关系至关重要